Clinical Trials Browser

OTHER × Interventional × Breast × Clear all

NCT03765983 2026-05-27

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

Phase 2 Terminated

17 enrolled 14 charts

Breast Neoplasms

NCT04107636 2026-05-27

MINIVAB

Phase NA Completed

Breast Neoplasms

NCT05088785 2026-05-27

FEStastic

Phase NA Active not recruiting

Breast Neoplasms

NCT05955833 2026-05-27

HER Image

Phase NA Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT06904625 2026-05-27

CAPT CTC

Phase NA Recruiting

BreastGenitourinary

Breast Neoplasms, Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT07216274 2026-05-27

Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT07252726 2026-05-27

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

Phase 4 Recruiting

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT07601490 2026-05-27

breast surgery

Phase NA Not yet recruiting

Breast Cancer Surgery Pain

NCT07608068 2026-05-27

Performance of Diffusion-weighted Imaging-based Virtual MR Elastography (vMRE) for Diagnosing Breast Cancer

Phase NA Active not recruiting

Breast Neoplasms

NCT07608081 2026-05-27

The Value of Time-Dependent Diffusion MRI and Magnetic Resonance Elastography in the Precise Diagnosis and Efficacy Assessment of Breast Cancer

Phase NA Recruiting

Breast Neoplasms

NCT07608848 2026-05-27

DOTA-STR-17126

Phase EARLY_PHASE1 Not yet recruiting

BreastGenitourinary

Breast Neoplasms, Neoplasms, Prostatic Neoplasms

NCT02422641 2026-05-26

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Phase 2 Recruiting

Breast Neoplasms, Meningeal Neoplasms

NCT03941756 2026-05-26

Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma

Phase NA Recruiting

BreastDermatologic

Melanoma, Inflammatory Breast Neoplasms

NCT04296162 2026-05-26

ORCHID

Phase 2 Completed

Breast Neoplasms

NCT04523857 2026-05-26

ABBY

Phase 2 Recruiting

Breast Neoplasms

NCT04648904 2026-05-26

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

Invasive Breast Cancer

NCT05472792 2026-05-26

CAMERAN

Phase 2 Recruiting

Breast Neoplasms

NCT06760507 2026-05-26

RSPH5973-23

Phase NA Recruiting

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT06772181 2026-05-26

PRO-ACTIVE

Phase NA Active not recruiting

Breast Neoplasms

NCT06812208 2026-05-26

Strategies to Decentralize Breast Ultrasound in Rwanda

Phase NA Enrolling by invitation

Breast Neoplasms

NCT06953882 2026-05-26

SELECT

Phase 2 Recruiting

HER2 Negative Breast Cancer

NCT07237256 2026-05-26

NoLEEta

Phase 3 Recruiting

Breast Neoplasms

NCT07426913 2026-05-26

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Phase NA Recruiting

Breast Neoplasms

NCT07599618 2026-05-26

PCDM

Phase NA Not yet recruiting

Breast Neoplasms

NCT07606287 2026-05-26

Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital

Phase NA Not yet recruiting

BreastCNSDermatologicGastrointestinalHead & Neck

Breast Neoplasms, Endocrine Gland Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Skin Neoplasms, Soft Tissue Neoplasms, Urogenital Neoplasms, Central Nervous System Neoplasms

NCT07607366 2026-05-26

NEPTAM

Phase NA Recruiting

Breast Cancer - Female

NCT07607548 2026-05-26

Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer

Phase NA Completed

Breast Neoplasms, Inflammation

NCT00585507 2026-05-22

Efficacy and Safety of 500mg of Fulvestrant

Phase 2 Active not recruiting

Breast Neoplasms

NCT00877500 2026-05-22

Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy

Phase 2 Active not recruiting

Bilateral Breast Carcinoma

NCT03125928 2026-05-22

Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer

Phase 2 Active not recruiting

HER2-positive Breast Cancer

NCT03449108 2026-05-22

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Phase 2 Active not recruiting

BreastEndocrineGynecologicHead & NeckSarcoma

Bone Neoplasms, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Giant Cell Tumor of Bone, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms, Thyroid Carcinoma, Anaplastic

NCT03627988 2026-05-22

MARTA

Phase 2 Completed

Breast Cancer Invasive

NCT03789097 2026-05-22

Vaccination With Flt3L, Radiation, and Poly-ICLC

Phase 1/2 Completed

BreastHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Lymphoma, Lymphoma, Non-Hodgkin

NCT04007770 2026-05-22

Acupuncture Pilot Study for Cancer-related Cognitive Function

Phase 2 Active not recruiting

BreastGastrointestinalGenitourinary

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04522648 2026-05-22

PROTECT

Phase NA Active not recruiting

Breast Neoplasms, Lymphedema

NCT04651452 2026-05-22

Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors

Phase NA Completed

Breast Neoplasms

NCT04699630 2026-05-22

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Phase 2 Completed

121 enrolled 15 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04764292 2026-05-22

SCEMAM

Phase 4 Completed

615 enrolled 11 charts

Breast Neoplasms

NCT05225428 2026-05-22

VERDI

Phase NA Recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Kidney Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT05417516 2026-05-22

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Phase 3 Recruiting

Breast Neoplasm Female

NCT05649072 2026-05-22

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Phase NA Recruiting

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT05989347 2026-05-22

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

Phase 1 Recruiting

Breast Neoplasms, Hyperinsulinism

NCT06075953 2026-05-22

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Phase 2 Recruiting

Carcinoma, Intraductal, Noninfiltrating

NCT06351332 2026-05-22

ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC

Phase 1/2 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06802172 2026-05-22

Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial

Phase NA Recruiting

BreastGastrointestinal

Intermittent Fasting, Breast Neoplasms, Rectal Neoplasms

NCT06954480 2026-05-22

DIAMOND

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06963905 2026-05-22

SIMONE

Phase 1/2 Recruiting

Triple Negative Breast Neoplasms

NCT07132034 2026-05-22

STREAK

Phase NA Not yet recruiting

Breast Neoplasms

NCT07335354 2026-05-22

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

Phase NA Recruiting

Breast Neoplasms

NCT07459673 2026-05-22

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

Phase 2 Recruiting

Breast Neoplasms